{
    "eid": "2-s2.0-85092287616",
    "title": "Therapeutic plasma exchange vs conventional treatment with intravenous high dose steroid for neuromyelitis optica spectrum disorders (NMOSD): a systematic review and meta-analysis",
    "cover-date": "2021-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neurology",
            "@code": "2808",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Neurology (clinical)",
            "@code": "2728",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Meta-analysis",
        "Neuromyelitis optica",
        "NMOSD",
        "Optic neuritis",
        "Plasma exchange",
        "Steroid"
    ],
    "authors": [
        "Sasitorn Siritho",
        "Tanawin Nopsopon",
        "Krit Pongpirul"
    ],
    "citedby-count": 17,
    "ref-count": 32,
    "ref-list": [
        "Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease",
        "Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelaination in a mouse model of neuromyelitis optica",
        "Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination",
        "Attack-related severity: a key factor in understanding the spectrum of idiopathic inflammatory demyelinating disorders",
        "The spectrum of neuromyelitis optica",
        "Neurodegeneration in multiple sclerosis and neuromyelitis optica",
        "A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease",
        "Clinical outcomes and predictive factors related to good outcomes in plasma exchange in severe attack of NMOSD and long extensive transverse myelitis: case series and review of the literature",
        "Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder",
        "Brain abnormalities in neuromyelitis optica spectrum disorder",
        "Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses",
        "Factors associated with the effectiveness of plasma exchange for the treatment of NMO-IgG-positive neuromyelitis optica spectrum disorders",
        "Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica",
        "Beneficial effect of plasma exchange in acute attack of neuromyelitis optica spectrum disorders",
        "Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica",
        "Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the American society for apheresis: the eighth special issue",
        "The mechanisms of action of plasma exchange",
        "Fulminant demyelinating diseases",
        "Revised diagnostic criteria for neuromyelitis optica",
        "International consensus diagnostic criteria for neuromyelitis optica spectrum disorders",
        "RoB 2: a revised tool for assessing risk of bias in randomised trials",
        "ROBINS-I: a tool for assessing risk of bias in non-randomized studies of interventions",
        "Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)",
        "Treatment of acute relapses in neuromyelitis optica: steroids alone versus steroids plus plasma exchange",
        "Plasma exchange: an effective add-on treatment of optic neuritis in neuromyelitis optica spectrum disorders",
        "A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: Intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous IVMP and PLEX",
        "Plasma exchange in severe attacks of neuromyelitis optica",
        "Plasmapheresis for neurological disorders",
        "Glucocorticoid resistance in inflammatory diseases",
        "Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice",
        "Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels",
        "Evaluation of clinical interest of anti-aquaporin-4 autoantibody follow up in neuromyelitis optica"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60020543",
            "affilname": "Bumrungrad International Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020543",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Baltimore",
            "@id": "60006183",
            "affilname": "Johns Hopkins Bloomberg School of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006183",
            "affiliation-country": "United States"
        }
    ],
    "funding": []
}